Tags

Type your tag names separated by a space and hit enter

Whole-blood immunoassay (SimpliRED) versus plasma immunoassay (NycoCard) for the diagnosis of clinically suspected deep vein thrombosis.
Vasa. 1997 May; 26(2):97-101.VASA

Abstract

BACKGROUND

The level of D-dimer in the blood reflects the level of lysed, cross-linked fibrin, and is a useful diagnostic marker in patients with clinically suspected deep vein thrombosis (DVT). In this study, two assays for the measurement of D-dimer levels were compared: the new, whole-blood immunoassay, SimpliRED, which can be performed at the patient's bedside in two minutes; and the plasma immunoassay, NycoCard.

PATIENTS AND METHODS

D-dimer levels were determined using these two techniques in 108 patients with clinically suspected DVT. To ascertain or rule out the diagnosis of DVT compression ultrasonography using a colour coded Duplex instrument was done. 8 doubtful cases were diagnosed by ascending phlebography. By these procedures DVT was confirmed in 33 patients and ruled out in the remaining 75 cases.

RESULTS

The SimpliRED assay exhibited a sensitivity of 1.0 (CI 0.89-1.0) and a specificity of 0.75 (CI 0.63-0.84); negative predictive value 1.0 (CI 0.94-1.0), positive predictive value 0.63 (CI 0.49-1.0). By contrast, the NycoCard assay displayed a sensitivity of 0.85 (CI 0.68-0.95) and a specificity of 0.65 (CI 0.53-0.76); negative predictive value 0.91 (CI 0.80-0.97), positive predictive value of 0.52 (CI 0.38-0.66).

CONCLUSION

The results show that the SimpliRED assay is a valuable tool in the diagnosis of clinically suspected DVT, especially when laboratory facilities are not accessible.

Authors+Show Affiliations

Department of Dermatology, Wilhelminenspital, Vienna.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Comparative Study
Journal Article

Language

eng

PubMed ID

9174385

Citation

Mayer, W, et al. "Whole-blood Immunoassay (SimpliRED) Versus Plasma Immunoassay (NycoCard) for the Diagnosis of Clinically Suspected Deep Vein Thrombosis." VASA. Zeitschrift Fur Gefasskrankheiten, vol. 26, no. 2, 1997, pp. 97-101.
Mayer W, Hirschwehr R, Hippmann G, et al. Whole-blood immunoassay (SimpliRED) versus plasma immunoassay (NycoCard) for the diagnosis of clinically suspected deep vein thrombosis. Vasa. 1997;26(2):97-101.
Mayer, W., Hirschwehr, R., Hippmann, G., Odpadlik, H., Bayer, P., & Partsch, H. (1997). Whole-blood immunoassay (SimpliRED) versus plasma immunoassay (NycoCard) for the diagnosis of clinically suspected deep vein thrombosis. VASA. Zeitschrift Fur Gefasskrankheiten, 26(2), 97-101.
Mayer W, et al. Whole-blood Immunoassay (SimpliRED) Versus Plasma Immunoassay (NycoCard) for the Diagnosis of Clinically Suspected Deep Vein Thrombosis. Vasa. 1997;26(2):97-101. PubMed PMID: 9174385.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Whole-blood immunoassay (SimpliRED) versus plasma immunoassay (NycoCard) for the diagnosis of clinically suspected deep vein thrombosis. AU - Mayer,W, AU - Hirschwehr,R, AU - Hippmann,G, AU - Odpadlik,H, AU - Bayer,P, AU - Partsch,H, PY - 1997/5/1/pubmed PY - 1997/5/1/medline PY - 1997/5/1/entrez SP - 97 EP - 101 JF - VASA. Zeitschrift fur Gefasskrankheiten JO - Vasa VL - 26 IS - 2 N2 - BACKGROUND: The level of D-dimer in the blood reflects the level of lysed, cross-linked fibrin, and is a useful diagnostic marker in patients with clinically suspected deep vein thrombosis (DVT). In this study, two assays for the measurement of D-dimer levels were compared: the new, whole-blood immunoassay, SimpliRED, which can be performed at the patient's bedside in two minutes; and the plasma immunoassay, NycoCard. PATIENTS AND METHODS: D-dimer levels were determined using these two techniques in 108 patients with clinically suspected DVT. To ascertain or rule out the diagnosis of DVT compression ultrasonography using a colour coded Duplex instrument was done. 8 doubtful cases were diagnosed by ascending phlebography. By these procedures DVT was confirmed in 33 patients and ruled out in the remaining 75 cases. RESULTS: The SimpliRED assay exhibited a sensitivity of 1.0 (CI 0.89-1.0) and a specificity of 0.75 (CI 0.63-0.84); negative predictive value 1.0 (CI 0.94-1.0), positive predictive value 0.63 (CI 0.49-1.0). By contrast, the NycoCard assay displayed a sensitivity of 0.85 (CI 0.68-0.95) and a specificity of 0.65 (CI 0.53-0.76); negative predictive value 0.91 (CI 0.80-0.97), positive predictive value of 0.52 (CI 0.38-0.66). CONCLUSION: The results show that the SimpliRED assay is a valuable tool in the diagnosis of clinically suspected DVT, especially when laboratory facilities are not accessible. SN - 0301-1526 UR - https://www.unboundmedicine.com/medline/citation/9174385/Whole_blood_immunoassay__SimpliRED__versus_plasma_immunoassay__NycoCard__for_the_diagnosis_of_clinically_suspected_deep_vein_thrombosis_ L2 - http://www.diseaseinfosearch.org/result/7087 DB - PRIME DP - Unbound Medicine ER -